Adrenocortical carcinoma staging: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Staging of adrenocortical carcinoma== | ==Staging of adrenocortical carcinoma== | ||
The AJCC has designated staging by TNM to define adrenocortical carcinoma<ref name=AJCC Cancer Staging Manual>Adrenal. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 516-7</ref> | The AJCC has designated staging by TNM to define adrenocortical carcinoma<ref name=AJCC Cancer Staging Manual>Adrenal. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 516-7</ref> | ||
===Staging according to TNM staging system=== | |||
{|{{table}} | |||
| Stage | |||
| T | |||
| N | |||
| M | |||
|- | |||
| I||T1||N0||M0 | |||
|- | |||
| II||T2||N0||M0 | |||
|- | |||
| III||T1||N1||M0 | |||
|- | |||
| ||T2||N1||M0 | |||
|- | |||
| ||T3||N0||M0 | |||
|- | |||
| IV||T3||N1||M0 | |||
|- | |||
| ||T4||N0||M0 | |||
|- | |||
| ||T4||N1||M0 | |||
|- | |||
| ||Any T||Any N||M1 | |||
|- | |||
|} | |||
===Tumor size (T)=== | |||
{| {{table}} | {| {{table}} | ||
Line 26: | Line 52: | ||
|} | |} | ||
===Lymph nodes (N)=== | |||
{| {{table}} | {| {{table}} | ||
Line 37: | Line 63: | ||
|} | |} | ||
===Metastasis (M)=== | |||
{| {{table}} | {| {{table}} | ||
| M0 | | M0 | ||
Line 43: | Line 69: | ||
|- | |- | ||
| M1||Distant metastasis. | | M1||Distant metastasis. | ||
|} | |} | ||
Revision as of 21:31, 27 August 2015
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma staging On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma staging |
Risk calculators and risk factors for Adrenocortical carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
According to the TNM staging system, there are four stages of adrenocortical cancer based on the tumor size, lymph nodes, and distant metastasis. Each stage is assigned a number and letter that designates the number of lymph nodes involved and presence/absence of distant metastasis.
Staging of adrenocortical carcinoma
The AJCC has designated staging by TNM to define adrenocortical carcinoma
Staging according to TNM staging system
Stage | T | N | M |
I | T1 | N0 | M0 |
II | T2 | N0 | M0 |
III | T1 | N1 | M0 |
T2 | N1 | M0 | |
T3 | N0 | M0 | |
IV | T3 | N1 | M0 |
T4 | N0 | M0 | |
T4 | N1 | M0 | |
Any T | Any N | M1 |
Tumor size (T)
TX | Primary tumor cannot be assessed. |
T0 | No evidence of primary tumor. |
T1 | Tumor ≤5 cm in greatest dimension, no extra-adrenal invasion. |
T2 | Tumor >5 cm, no extra-adrenal invasion. |
T3 | Tumor of any size with local invasion, but not invading adjacent organs. |
T4 | Tumor of any size with invasion of adjacent organs. |
Lymph nodes (N)
NX | Regional lymph nodes cannot be assessed. |
N0 | No regional lymph node metastasis. |
N1 | Metastases in regional lymph node(s). |
Metastasis (M)
M0 | No distant metastasis. |
M1 | Distant metastasis. |